arrow
H

Holly C. Groom

Kaiser Permanente
H指数:25
被引数:3,569

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Meningococcal B Vaccination Patterns Across 10 Integrated Health Systems Within the Vaccine Safety Datalink, 2015-2023

脑膜炎球菌B疫苗接种模式:基于疫苗安全数据链的10个整合医疗系统,2015-2023

2026-08-010
PRE
Household Transmission of SARS-CoV-2 in Washington and Oregon, United States, 2022-2024

2022-2024年美国华盛顿州和俄勒冈州的家庭内SARS-CoV-2传播

2026-07-200
PRE
Differences in influenza vaccination coverage by race and ethnicity across age groups in the Vaccine Safety Datalink, 2017–18 through 2022–23 influenza seasons

2017–18至2022–23流感季疫苗安全数据链中,不同年龄组按种族和族裔划分的流感疫苗接种覆盖率差异

Vaccine
IF3.5
2025-09-040
PRE
Parental intent to vaccinate children with the updated 2023–2024 COVID-19 vaccine

家长为孩子接种更新版2023–2024年COVID-19疫苗的意愿

Vaccine
IF3.5
2025-08-230
PRE
Increased Identification of Vaccines for Vaccine Safety Surveillance Through Linkage With the Minnesota Immunization Information Connection as of December 31, 2023

截至2023年12月31日,通过与明尼苏达州预防接种信息连接的链接,增加了用于疫苗安全监测的疫苗识别

2024-09-280
PRE
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines
2024-01-047
OAAI
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020
2023-04-218
OAAI
Association of mRNA Vaccination With Clinical and Virologic Features of COVID-19 Among US Essential and Frontline Workers
2022-10-1823
OA
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial

重复接种疫苗对18-64岁医护人员四价细胞培养和重组流感疫苗免疫原性的影响: 一项随机、开放标签试验

2022-08-299
OAAI
Detection and Stability of SARS-CoV-2 in Three Self-Collected Specimen Types: Flocked Midturbinate Swab (MTS) in Viral Transport Media, Foam MTS, and Saliva
2022-06-291
OAAI
Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
2022-05-1229
OAAI